Confident Investing Starts With TipRanks Premium

Go Ultimate 55% OFF

Click Therapeutics Inc: Valuation, Funding & Investors

80 White St New York, 10013, UShttps://www.clicktherapeutics.com/Digital Health

Click Therapeutics Inc develops prescription digital therapeutics—software-based medical interventions—targeting neuropsychiatric and other chronic conditions. The company focuses on designing clinically validated, evidence-driven digital interventions and collaborating with healthcare providers, payers, and regulators to integrate its software-as-a-medical-device solutions into clinical care pathways.

Leadership & Board

Current Number of Employees: 103
Current LinkedIn Followers: 31,962

Latest Estimated Valuation

Total Amount Raised: $49M
Total Funding Rounds: 1
Latest Funding Amount: $49M
Latest Funding Round: Series C

Company Momentum Positive

Articles Published on TipRanks1

LinkedIn Trend+0.30% followers

Workforce Trend+0.0% employees

Click Therapeutics Inc LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.

Employee Trend

Click Therapeutics Inc had 103 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.

103Latest Employee Count

0(0.00%)Week-Over-Week Change

Social Trend

Click Therapeutics Inc had 31,962 followers as of October 26, 2026. The number of followers increased by 96 (0.30%) week-over-week.

31,962Latest Followers Count

96(0.30%)Week-Over-Week Change

Funding Round

Funding Date	Funding Round	Amount Raised	Post-Money Valuation
Apr 19, 2025	Series C	$48.60M	―

Investors

Investor Name	Funding Round
Dassault Systemes	Series C

Similar Companies

A snapshot of private companies similar to Click Therapeutics Inc, helping you discover and navigate related company profiles.

Kernal Biologics Inc

Related News and Analysis

FDA Guidance Opens Pathway for Software-Enhanced Drug Labeling

FDA Guidance Opens Pathway for Software-Enhanced Drug Labeling

According to a recent LinkedIn post from Click Therapeutics Inc, the U.S. FDA has issued final guidance on Prescription Drug Use-Related Software that explicitly allows benefits from certain digital tools

1w ago

Click Therapeutics Highlights Access Strategy for FDA-Authorized Schizophrenia Treatment

Click Therapeutics Highlights Access Strategy for FDA-Authorized Schizophrenia Treatment

According to a recent LinkedIn post from Click Therapeutics Inc, the company is highlighting sustained interest in Motivista, described as the first FDA‑authorized treatment specifically indicated for the negative symptoms

2w ago

FDA Clearance Positions Click Therapeutics’ Motivista for Commercial Rollout

FDA Clearance Positions Click Therapeutics’ Motivista for Commercial Rollout

According to a recent LinkedIn post from Click Therapeutics Inc, the company is highlighting U.S. FDA 510(k) clearance for Motivista (CT-155), a smartphone-based prescription digital therapeutic for negative symptoms of

3w ago

Phase 3 Schizophrenia Trial Results Highlight Potential of Click Therapeutics’ CT-155

Phase 3 Schizophrenia Trial Results Highlight Potential of Click Therapeutics’ CT-155

According to a recent LinkedIn post from Click Therapeutics Inc, results from the CONVOKE Phase 3 trial of its investigational prescription digital therapeutic CT-155 for negative symptoms in schizophrenia have

1M ago

Click Therapeutics Adds Former Novo Nordisk Executive to Board

Click Therapeutics Adds Former Novo Nordisk Executive to Board

According to a recent LinkedIn post from Click Therapeutics Inc, former Novo Nordisk Inc. President and Executive Vice President, Head of North America Operations, Doug Langa, has joined the company’s

3M ago

Click Therapeutics Sharpens Migraine Focus and Femtech Strategy in Data-Driven Growth Push

Click Therapeutics Sharpens Migraine Focus and Femtech Strategy in Data-Driven Growth Push

Click Therapeutics Inc is a digital therapeutics company that spent the week spotlighting migraine, particularly menstrual migraine, as a major unmet need in women’s health. The company underscored that migraine

4M ago

Click Therapeutics Highlights Femtech Opportunity in Menstrual Migraine and Data Integration

Click Therapeutics Highlights Femtech Opportunity in Menstrual Migraine and Data Integration

According to a recent LinkedIn post from Click Therapeutics Inc, the company is drawing attention to menstrual migraine as a significant but under-addressed gap within women’s digital health. The post

4M ago

Click Therapeutics Expands Migraine Digital Therapeutics Strategy and Showcases Growth Agenda

Click Therapeutics Expands Migraine Digital Therapeutics Strategy and Showcases Growth Agenda

Click Therapeutics Inc is a digital therapeutics company developing evidence-based software treatments, and this weekly recap summarizes a series of updates on its migraine strategy and corporate positioning. The company

4M ago

Click Therapeutics Highlights Expansion Into OTC Digital Migraine Therapeutics

Click Therapeutics Highlights Expansion Into OTC Digital Migraine Therapeutics

According to a recent LinkedIn post from Click Therapeutics Inc, the company is emphasizing the scale of unmet need in migraine care and the constraints of current delivery systems. The

4M ago

Click Therapeutics CEO Highlights Talent Strategy at HLTH Europe

Click Therapeutics CEO Highlights Talent Strategy at HLTH Europe

According to a recent LinkedIn post from Click Therapeutics Inc, Founder and CEO David Benshoof Klein is scheduled to speak at the HLTH Europe conference in Amsterdam on June 17.

4M ago